Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22110
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKioukia, N.en
dc.contributor.authorBekris, S.en
dc.contributor.authorAntoniou, K.en
dc.contributor.authorPapadopoulou-Daifoti, Z.en
dc.contributor.authorChristofidis, I.en
dc.date.accessioned2015-11-24T19:21:34Z-
dc.date.available2015-11-24T19:21:34Z-
dc.identifier.issn0306-4530-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22110-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAntidepressive Agents, Tricyclic/pharmacologyen
dc.subjectBehavior, Animal/drug effectsen
dc.subjectChronic Diseaseen
dc.subjectDisease Models, Animalen
dc.subjectEating/drug effectsen
dc.subjectImipramine/pharmacologyen
dc.subjectMaleen
dc.subjectRatsen
dc.subjectRats, Sprague-Dawleyen
dc.subjectRats, Wistaren
dc.subjectSerum Albumin/metabolismen
dc.subjectSpecies Specificityen
dc.subjectStress, Physiological/blood/drug therapy/*physiopathologyen
dc.subjectThyroid Function Testsen
dc.subjectThyroid Gland/drug effects/*metabolismen
dc.subjectThyrotropin/blooden
dc.subjectThyroxine/blooden
dc.subjectTriiodothyronine/blooden
dc.titleEffects of chronic mild stress (CMS) on thyroid hormone function in two rat strainsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10737696-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0306453099000517/1-s2.0-S0306453099000517-main.pdf?_tid=fb2e406ee3376889bc9ee0b599336b45&acdnat=1332925192_8dfe42842da3bf41084f1e635505c700-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2000-
heal.abstractThis work was carried out to assess the effects of chronic mild stress (CMS) on thyroid function. The CMS model produced an anhedonic effect (reduced preference to sucrose) in Sprague-Dawley and Wistar rats and this effect was reversed by imipramine (IMI) treatment. The effects of CMS on thyroid function were assessed by measuring tT4 (total Thyroxine), tT3 (total Triiodothyronine), TSH (Thyroid Stimulating Hormone) and fT4 (free Thyroxine) serum levels with appropriate immunoassays. CMS increased tT4 and tT3 serum levels in Sprague-Dawley and Wistar rats, but not TSH and fT4 serum levels. Imipramine (IMI) treatment normalized tT4 values. Albumin which binds a fraction of peripheral tT4 and tT3 was also significantly increased in response to CMS, possibly contributing to tT4 and tT3 elevations. The above findings suggest an impact of CMS on thyroid function, especially in tT4 values the changes being reversed with IMI treatment.en
heal.journalNamePsychoneuroendocrinologyen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kioukia-2000-Effects of chronic m.pdf141.32 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons